Invesco’s VolitionRx Ltd VNRX Stock Holding History

Invesco’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,033	Closed	-$78K	–	4038
2021 Q1	$78K	Buy	1,033 +46	+5%	+$3.95K	﹤0.01%	3791
2020 Q4	$77K	Buy	+987	New	+$68K	﹤0.01%	3678

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco's VNRX Position: Q2 2021 in Review

Invesco sold out of VolitionRx Ltd (VNRX) in Q2 2021, closing a stake of 1,033 shares — an estimated $78K sold.

Invesco first reported a position in VNRX in Q4 2020 and held it in 2 quarters. The position peaked at $78K in Q1 2021. 46 funds tracked by Wall St. Rank hold VNRX as of Q2 2021.

Invesco reported no remaining VolitionRx Ltd position as of Q2 2021 after selling out during the quarter.
Invesco sold 1,033 VolitionRx Ltd shares in Q2 2021, an estimated $78K.
Invesco first reported a position in VolitionRx Ltd in Q4 2020 and held it in 2 quarters.
Invesco's VolitionRx Ltd position peaked at $78K in Q1 2021.
46 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.